Copenhagen, Denmark

Signe M Christensen

USPTO Granted Patents = 10 

 

 

Average Co-Inventor Count = 7.8

ph-index = 7

Forward Citations = 486(Granted Patents)


Location History:

  • København N, DK (2009 - 2011)
  • København, DK (2013)
  • Kobenhavn, DK (2017)
  • Copenhagen, DK (2010 - 2018)

Company Filing History:


Years Active: 2009-2018

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):

Title: Signe M Christensen: Innovator in Antisense Pharmaceuticals

Introduction

Signe M Christensen is a prominent inventor based in Copenhagen, Denmark. She has made significant contributions to the field of pharmaceuticals, particularly in the development of novel antisense therapies. With a total of 10 patents to her name, her work has the potential to impact medical treatments significantly.

Latest Patents

One of her latest patents focuses on a novel class of pharmaceuticals that comprises a Locked Nucleic Acid (LNA) used in antisense therapy. These innovative oligonucleotides exhibit improved antisense properties. The oligonucleotides are composed of at least one LNA selected from beta-D-thio/amino-LNA or alpha-L-oxy/thio/amino-LNA. Additionally, the oligonucleotides may include DNA and/or RNA nucleotides, enhancing their therapeutic potential.

Career Highlights

Throughout her career, Signe has worked with notable companies such as Santaris Pharma A/S and Roche Innovation Center Copenhagen A/S. Her experience in these organizations has allowed her to refine her expertise in pharmaceutical innovation and development.

Collaborations

Signe has collaborated with talented individuals in her field, including Troels Koch and Christoph Rosenbohm. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Signe M Christensen is a trailblazer in the field of antisense pharmaceuticals, with a strong portfolio of patents and a career marked by significant collaborations. Her innovative work continues to pave the way for advancements in medical therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…